Early diagnosis of chronic kidney disease in patients with diabetes in France: multidisciplinary expert opinion, prevention value and practical recommendations

References

• Rossing P, Caramori ML, Chan JCN, et al. Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence. Kidney Int. 2022;102(5):990–999. PMID: 36272755. doi: 10.1016/j.kint.2022.06.013
   PubMed Web of Science ®Google Scholar
• Wu B, Bell K, Stanford A, et al. Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012. BMJ Open Diabetes Res Care. 2016;4(1):e000154. doi: 10.1136/bmjdrc-2015-000154
   PubMed Web of Science ®Google Scholar
• Kainz A, Hronsky M, Stel VS, et al. Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025. Nephrol Dial Transplant. 2015;30(4):iv113–8. doi: 10.1093/ndt/gfv073
   PubMedGoogle Scholar
• American Diabetes Association. Standards of medical care in diabetes-2022 abridged for primary care providers. Clin Diabetes. 2022;40(1):10–38. doi: 10.2337/cd22-as01
   PubMedGoogle Scholar
• Assurance Maladie. Fiche pathologie. Last Updated on 18 Jan 2023. Available at: https://www.ameli.fr/sites/default/files/2020_fiche_diabete_0.pdf Last access: 05 Jul 2023
   Google Scholar
• Assogba GF, Couchoud C, Roudier C, et al. Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: the ENTRED surveys (2001 and 2007). Diabetes metab. 2012;38(6):558–566. doi: 10.1016/j.diabet.2012.08.004
   PubMed Web of Science ®Google Scholar
• Lassalle M, Monnet E, Ayav C, et al. REIN registry. 2017 annual report digest of the renal epidemiology Information Network (REIN) registry. Transplant Int. 2019;32(9):892–902. Epub 2019 Jul 4. PMID: 31148236. doi: 10.1111/tri.13466
   PubMed Web of Science ®Google Scholar
• Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013;24(2):302–308. Epub 2013 Jan 29. PMID: 23362314; PMCID: PMC3559486. doi: 10.1681/ASN.2012070718
   PubMed Web of Science ®Google Scholar
• Assogba FG, Couchoud C, Hannedouche T, et al. Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007-2011. Diabetologia. 2014;57(4):718–728. doi: 10.1007/s00125-014-3160-9
   PubMed Web of Science ®Google Scholar
• Rangaswami J, Bhalla V, de Boer IH, et al. Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease: a scientific statement from the American heart association. Circulation. 2020;142(17):e265–e86. doi: 10.1161/CIR.0000000000000920
   PubMed Web of Science ®Google Scholar
• Maisons V, Halimi JM, Fauchier G, et al. Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study. Diabetes metab. 2023;49(3):101441. Epub 2023 Mar 15. PMID: 36931430. doi: 10.1016/j.diabet.2023.101441
   PubMed Web of Science ®Google Scholar
• ElSayed NA, Aleppo G, Aroda VR, et al. On behalf of the American Diabetes Association. 11. Chronic kidney disease and risk management: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S191–S202. PMID: 36507634; PMCID: PMC9810467. doi: 10.2337/dc23-S011
   PubMedGoogle Scholar
• de Boer IH, Khunti K, Sadusky T, et al. Diabetes management in chronic kidney disease: a consensus report by the American diabetes association (ADA) and kidney disease: improving Global outcomes (KDIGO). Kidney Int. 2022;102(5):974–989. Epub 2022 Oct 3. PMID: 36202661. doi: 10.1016/j.kint.2022.08.012
   PubMed Web of Science ®Google Scholar
• Chronic kidney disease: assessment and management. NICE guideline [NG203]. Published: 25 Aug 2021. Last updated: 24 Nov 2021. Available at: https://www.nice.org.uk/guidance/ng203 Last access: 05 Jul 2023
   Google Scholar
• Shubrook JH, Neumiller JJ, Wright E. Management of chronic kidney disease in type 2 diabetes: screening, diagnosis and treatment goals, and recommendations. Postgrad Med. 2021;134:1–12. doi: 10.1080/00325481.2021.2009726
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Tummalapalli SL, Boulware LE, et al. Conference participants. The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: improving Global outcomes (KDIGO) controversies Conference. Kidney Int. 2021;99(1):34–47. 18.998 Q1. Epub 2020 Oct 27. PMID: 33127436. doi: 10.1016/j.kint.2020.10.012
   PubMed Web of Science ®Google Scholar
• Gaut JP. Time to abandon renalism: patients with kidney diseases deserve more. Clin J Am Soc Nephrol. 2023;18(4):419–420. Epub 2023 Mar 10. PMID: 36913251; PMCID: PMC10103202. doi: 10.2215/CJN.0000000000000127
   PubMed Web of Science ®Google Scholar
• Kidney Disease Improving Global Outcomes. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–163.
   Web of Science ®Google Scholar
• French National Authority for Health (Haute Autorité de Santé - HAS). Rapport d’évaluation technologique : Evaluation du débit de filtration glomérulaire et du dosage de la créatininémie dans le diagnostic de la maladie rénale chronique chez l’adulte. Jan 2012. (in French). PDF available at: https://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/evaluation_du_debit_de_filtration_glomerulaire_et_du_dosage_de_la_creatininemie_dans_le_diagnostic_de_la_maladie_renale_chronique_chez_ladulte_-_fiche_buts.pdf Last access: 5 Jul 2023
   Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med. 2011;155(6): 408]. Ann Intern Med. 2009;150(9):604–612. doi: 10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies Conference report [published correction appears in kidney int. 2011;80(9): 1000] [published correction appears in kidney int. 2011;80(9): 1000]. Kidney Int. 2011;80(1):17–28. doi: 10.1038/ki.2010.483
   PubMed Web of Science ®Google Scholar
• Inker LA, Schmid CH, Tighiouart H, et al. CKD-EPI investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. Erratum in: N Engl J Med. 2012;367(7):681. Erratum in: N Engl J Med. 2012 Nov 22;367(21):2060. PMID: 22762315; PMCID: PMC4398023. N Engl J Med. 2012;367(1):20–29. doi: 10.1056/NEJMoa1114248
   PubMed Web of Science ®Google Scholar
• Delanaye P, Mariat C, Cavalier E, et al. The « race » correction in estimating glomerular filtration rate: an European point of view. Curr Opin Nephrol Hypertens. 2021;30(6):525–530. PMID: 34456237. doi: 10.1097/MNH.0000000000000739
   PubMed Web of Science ®Google Scholar
• Gansevoort RT, Anders HJ, Cozzolino M, et al. What should European nephrology do with the new CKD-EPI equation? Nephrol Dial Transplant. 2023;38(1):1–6. doi: 10.1093/ndt/gfac254
   PubMed Web of Science ®Google Scholar
• Zingano CP, Escott GM, Rocha BM, et al. 2009 CKD-EPI glomerular filtration rate estimation in black individuals outside the United States: a systematic review and meta-analysis. Clin Kidney J. 2023;16:322–330. doi: 10.1093/ckj/sfac238
   Web of Science ®Google Scholar
• Delanaye P, Vidal-Petiot E, Björk J, et al. Performance of creatinine-based equations to estimate glomerular filtration rate in White and black populations in Europe, Brazil and Africa. Nephrol Dial Transplant. 2023;38(1):106–118. 7.186 Q1. PMID: 36002032. doi: 10.1093/ndt/gfac241
   PubMed Web of Science ®Google Scholar
• Pottel H, Björk J, Courbebaisse M, et al. Development and validation of a modified full age spectrum creatinine-based equation to estimate glomerular filtration rate: a cross-sectional analysis of pooled data. Ann Intern Med. 2021;174(2):183–191. doi: 10.7326/M20-4366
   PubMed Web of Science ®Google Scholar
• Delanaye P, Jager KJ, Bökenkamp A, et al. CKD: a call for an age-adapted definition. J Am Soc Nephrol. 2019;30(10):1785–1805. Epub 2019 Sep 10. PMID: 31506289; PMCID: PMC6779354. doi: 10.1681/ASN.2019030238
   PubMed Web of Science ®Google Scholar
• Coresh J, Gansevoort RT, Prognosis Consortium CKD, et al. Current CKD definition takes into account both relative and absolute risk. J Am Soc Nephrol. 2020;31(2):447–448. doi: 10.1681/ASN.2019101049. Epub 2019 Dec 23. PMID: 31871274; PMCID: PMC7003310
   PubMed Web of Science ®Google Scholar
• Keller N, Ruppert M, Fourtage M, et al. Médicaments du système cardiovasculaire et fonction rénale : les pièges de l’adaptation rénale [Cardiovascular drugs and renal function: Pitfall of renal adaptation]. Nephrol Ther. 2019;15(2):97–103. in FrenchEpub 2019 Mar 1. PMID: 30827822. doi: 10.1016/j.nephro.2018.11.005
   PubMedGoogle Scholar
• French National Authority for Health (Haute Autorité de Santé - HAS). Guide du parcours de soins – Maladie rénale chronique de l’adulte (MRC). 1 Jul 2021. (in French). PDF available at: https://www.has-sante.fr/upload/docs/application/pdf/2021-09/guide__mrc.pdf Last access: 05 Jul 2023
   Google Scholar
• Geddes CC, Woo YM, Brady S. Glomerular filtration rate–what is the rationale and justification of normalizing GFR for body surface area? Nephrol Dial Transplant. 2008;23(1):4–6. Epub 2007 Oct 2. PMID: 17913737. doi: 10.1093/ndt/gfm662
   PubMed Web of Science ®Google Scholar
• Delanaye P, Radermecker RP, Rorive M, et al. Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. Nephrol Dial Transplant. 2005;20(10):2024–2028. Epub 2005 Jul 19. PMID: 16030047. doi: 10.1093/ndt/gfh983
   PubMed Web of Science ®Google Scholar
• Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-Based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–1749. doi: 10.1056/NEJMoa2102953
   PubMed Web of Science ®Google Scholar
• Heyman SN, Raz I, Dwyer JP, et al. Diabetic proteinuria revisited: updated physiologic perspectives. Cells. 2022;11(18):2917. PMID: 36139492; PMCID: PMC9496872. doi: 10.3390/cells11182917
   PubMed Web of Science ®Google Scholar
• Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol. 2006;17(8):2106–2111. Epub 2006 Jul 6. PMID: 16825333. doi: 10.1681/ASN.2005121288
   PubMed Web of Science ®Google Scholar
• Miller WG, Bruns DE, Hortin GL, et al. National Kidney Disease Education Program-IFCC Working Group on Standardization of Albumin in Urine. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem. 2009;55(1):24–38. Epub 2008 Nov 21. PMID: 19028824. doi: 10.1373/clinchem.2008.106567
   PubMed Web of Science ®Google Scholar
• French National Authority for Health (Haute Autorité de Santé – HAS 2011). Évaluation du rapport albuminurie/créatininurie dans le diagnostic de la maladie rénale chronique chez l’adulte - Rapport d’évaluation. 28 Dec 2011. (in French). Available at: https://www.has-sante.fr/jcms/c_1169049/fr/evaluation-du-rapport-albuminurie/creatininurie-dans-le-diagnostic-de-la-maladie-renale-chronique-chez-l-adulte-rapport-d-evaluation Last access: 05 Jul 2023
   Google Scholar
• Halimi JM, Hadjadj S, Aboyans V, et al. Microalbuminuria and urinary albumin excretion: French clinical practice guidelines. Diabetes metab. 2007;33(4):303–309. doi: 10.1016/j.diabet.2007.06.001
   PubMed Web of Science ®Google Scholar
• Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis [published correction appears in Lancet. 2013 Feb 2;381(9864): 374]. Lancet. 2012;380(9854):1662–1673. doi: 10.1016/S0140-6736(12)61350-6
   PubMed Web of Science ®Google Scholar
• Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3(7):514–525. doi: 10.1016/S2213-8587(15)00040-6
   PubMed Web of Science ®Google Scholar
• Khan MS, Shahid I, Anker SD, et al. Albuminuria and heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2023;81(3):270–282. doi: 10.1016/j.jacc.2022.10.028
   PubMed Web of Science ®Google Scholar
• de Zeeuw D, Remuzzi G, Parving HH, et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int. 2004;65(6):2309–2320. doi: 10.1111/j.1523-1755.2004.00653.x
   PubMed Web of Science ®Google Scholar
• Coresh J, Heerspink HJL, Sang Y, et al. Chronic kidney disease prognosis Consortium and chronic kidney disease epidemiology collaboration. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes Endocrinol. 2019;7(2):115–127. Epub 2019 Jan 8. PMID: 30635225; PMCID: PMC6379893. doi: 10.1016/S2213-8587(18)30313-9
   PubMed Web of Science ®Google Scholar
• Palmer BF. Change in albuminuria as a surrogate endpoint for cardiovascular and renal outcomes in patients with diabetes. Diab Obes Metab. 2023;25(6):1434–1443. Epub 2023 Mar 8. PMID: 36809555. doi: 10.1111/dom.15030
   PubMed Web of Science ®Google Scholar
• Pafundi PC, Garofalo C, Galiero R, et al. Role of albuminuria in detecting cardio-renal risk and outcome in diabetic subjects. Diagnostics. 2021;11(2):290. PMID: 33673215; PMCID: PMC7918197. doi: 10.3390/diagnostics11020290
   Web of Science ®Google Scholar
• Ragot S, Saulnier PJ, Velho G, et al. Dynamic changes in renal function are associated with major cardiovascular events in patients with type 2 diabetes. Diabetes Care. 2016;39(7):1259–1266. doi: 10.2337/dc15-2607
   PubMed Web of Science ®Google Scholar
• Pinier C, Gatault P, François M, et al. Renal function at the time of nephrology referral but not dialysis initiation as a risk for death in patients with diabetes mellitus. Clin Kidney J. 2018;11(6):762–768. doi: 10.1093/ckj/sfy032
   PubMed Web of Science ®Google Scholar
• Smart NA, Dieberg G, Ladhani M, et al. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. 2014 CD007333 PMID: 24938824 doi: 10.1002/14651858.CD007333.pub2
   PubMed Web of Science ®Google Scholar
• Smart NA, Titus TT. Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am j med. 2011;124(11):1073–80.e2. PMID: 22017785. doi: 10.1016/j.amjmed.2011.04.026
   PubMed Web of Science ®Google Scholar
• Collier W, Inker LA, Haaland B, et al. Chronic kidney disease epidemiology collaboration (CKD-EPI)*. Evaluation of variation in the performance of GFR slope as a surrogate endpoint for kidney failure in clinical trials that differ by severity of CKD. Clin J Am Soc Nephrol. 2023;18(2):183–192. Epub 2023 Jan 19. PMID: 36754007. doi: 10.2215/CJN.0000000000000050
   PubMedGoogle Scholar
• Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553–1559. doi: 10.1001/jama.2011.451
   PubMed Web of Science ®Google Scholar
• Tangri N, Grams ME, Levey AS, et al. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis [published correction appears in JAMA. 2016;315(8): 822]. JAMA. 2016;315(2):164–174. doi: 10.1001/jama.2015.18202
   PubMed Web of Science ®Google Scholar
• Peeters MJ, van Zuilen AD, van den Brand JA, et al. Validation of the kidney failure risk equation in European CKD patients. Nephrol Dial Transplant. 2013;28(7):1773–1779. doi: 10.1093/ndt/gft063
   PubMed Web of Science ®Google Scholar
• Grams ME, Li L, Greene TH, et al. Estimating time to ESRD using kidney failure risk equations: results from the African American study of kidney disease and hypertension (AASK). Am J Kidney Dis. 2015;65(3):394–402. doi: 10.1053/j.ajkd.2014.07.026
   PubMed Web of Science ®Google Scholar
• Wang Y, Nguyen FNHL, Allen JC, et al. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia. BMC Nephrol. 2019;20(1):451. doi: 10.1186/s12882-019-1643-0
   PubMed Web of Science ®Google Scholar
• Hundemer GL, Tangri N, Sood MM, et al. Performance of the kidney failure risk equation by disease etiology in advanced CKD. Clin J Am Soc Nephrol. 2020;15(10):1424–1432. Epub 2020 Sep 14. PMID: 32928746; PMCID: PMC7536763. doi: 10.2215/CJN.03940320
   PubMed Web of Science ®Google Scholar
• Lennartz CS, Pickering JW, Seiler-Mußler S, et al. External validation of the kidney failure risk equation and re-calibration with addition of ultrasound parameters. Clin J Am Soc Nephrol. 2016;11(4):609–615. doi: 10.2215/CJN.08110715
   PubMed Web of Science ®Google Scholar
• Winnicki E, McCulloch CE, Mitsnefes MM, et al. Use of the kidney failure risk equation to determine the risk of progression to end-stage renal disease in children with chronic kidney disease. JAMA Pediatr. 2018;172(2):174–180. doi: 10.1001/jamapediatrics.2017.4083
   PubMed Web of Science ®Google Scholar
• Hundemer GL, Tangri N, Sood MM, et al. The effect of age on performance of the kidney failure risk equation in advanced CKD. Kidney Int Rep. 2021;6(12):2993–3001. PMID: 34901569; PMCID: PMC8640561. doi: 10.1016/j.ekir.2021.09.006
   PubMed Web of Science ®Google Scholar
• Al-Wahsh H, Tangri N, Quinn R, et al. Accounting for the competing risk of death to predict kidney failure in adults with stage 4 chronic kidney disease. JAMA Netw Open. 2021;4(5):e219225. PMID: 33944922; PMCID: PMC8097501. doi: 10.1001/jamanetworkopen.2021.9225
   PubMed Web of Science ®Google Scholar
• Major RW, Shepherd D, Medcalf JF, et al. The kidney failure risk equation for prediction of end stage renal disease in UK primary care: an external validation and clinical impact projection cohort study. PLOS Med. 2019;16(11):e1002955. Erratum in: PLoS Med. 2020 Jul 24;17(7):e1003313. PMID: 31693662; PMCID: PMC6834237. doi: 10.1371/journal.pmed.1002955
   PubMed Web of Science ®Google Scholar
• Hingwala J, Wojciechowski P, Hiebert B, et al. Risk-based triage for nephrology referrals using the kidney failure risk equation. Can J Kidney Health Dis. 2017;4:2054358117722782. PMID: 28835850; PMCID: PMC5555495. doi: 10.1177/2054358117722782
   Google Scholar
• NICE 2021. Chronic kidney disease: assessment and management. Available at: https://www.nice.org.uk/guidance/NG203 Last access: 5 Jul 2023
   Google Scholar
• Clase CM, Carrero JJ, Ellison DH, et al. Conference participants. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a kidney disease: improving Global outcomes (KDIGO) controversies Conference. Kidney Int. 2020;97(1):42–61. Epub 2019 Oct 10. PMID: 31706619. doi: 10.1016/j.kint.2019.09.018
   PubMed Web of Science ®Google Scholar
• Sousa AG, Cabral JV, El-Feghaly WB, et al. Hyporeninemic hypoaldosteronism and diabetes mellitus: pathophysiology assumptions, clinical aspects and implications for management. World J Diabetes. 2016;7(5):101–111. PMID: 26981183; PMCID: PMC4781902. doi: 10.4239/wjd.v7.i5.101
   PubMedGoogle Scholar
• Cooper LB, Savarese G, Carrero JJ, et al. Clinical and research implications of serum versus plasma potassium measurements. Eur J Heart Fail. 2019;21(4):536–537. Epub 2018 Nov 28. PMID: 30485595. doi: 10.1002/ejhf.1371
   PubMed Web of Science ®Google Scholar
• Gruson G, Jadoul M, Deltombe M, et al. MO739 evaluation of a capillary blood potassium measurement method in healthy volunteers and in chronic haemodialysis patients. Available at; https://academic.oup.com/ndt/article/37/Supplement_3/gfac079.018/6577586 Last access: 5 Jul 2023
   Google Scholar
• Rossignol P, Silva-Cardoso J, Kosiborod MN, et al. Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease. Pharmacol Res. 2022;182:106277. doi: 10.1016/j.phrs.2022.106277
   PubMed Web of Science ®Google Scholar
• Kovesdy CP, Appel LJ, Grams ME, et al. Potassium homeostasis in health and disease: a scientific workshop cosponsored by the National kidney Foundation and the American Society of Hypertension. J Am Soc Hypertens. 2017;11(12):783–800. Epub 2017 Oct 10. PMID: 29030153. doi: 10.1016/j.jash.2017.09.011
   PubMed Web of Science ®Google Scholar
• Kovesdy CP, Matsushita K, Sang Y, et al. CKD prognosis Consortium. Serum potassium and adverse outcomes across the range of kidney function: a CKD prognosis Consortium meta-analysis. Eur Heart J. 2018;39(17):1535–1542. PMID: 29554312; PMCID: PMC5930249. doi: 10.1093/eurheartj/ehy100
   PubMedGoogle Scholar
• Collins AJ, Pitt B, Reaven N, et al. Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes. Am J Nephrol. 2017;46(3):213–221. doi: 10.1159/000479802
   PubMed Web of Science ®Google Scholar
• Bandak G, Sang Y, Gasparini A, et al. Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) project. J Am Heart Assoc. 2017;6(7):e005428. PMID: 28724651; PMCID: PMC5586281. doi: 10.1161/JAHA.116.005428
   PubMed Web of Science ®Google Scholar
• Khosla N, Kalaitzidis R, Bakris GL. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade. Epub 2009 Sep 9. PMID: 19738369. Am J Nephrol. 2009;30(5):418–424. doi: 10.1159/000237742
   PubMed Web of Science ®Google Scholar
• Noori N, Kalantar-Zadeh K, Kovesdy CP, et al. Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis. 2010;56(2):338–347. Epub 2010 Jun 30. PMID: 20580474; PMCID: PMC2910783. doi: 10.1053/j.ajkd.2010.03.022
   PubMed Web of Science ®Google Scholar
• Smyth A, Dunkler D, Gao P, et al. ONTARGET and TRANSCEND investigators. The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney Int. 2014;86(6):1205–1212. Epub 2014 Jun 11. PMID: 24918156. doi: 10.1038/ki.2014.214
   PubMed Web of Science ®Google Scholar
• Patel S, Lam PH, Kanonidis EI, et al. Renin-angiotensin inhibition and outcomes in HFrEF and advanced kidney disease. Am j med. 2023;136(7):677–686. doi: 10.1016/j.amjmed.2023.03.017
   PubMed Web of Science ®Google Scholar
• Ku E, Inker LA, Tighiouart H, et al. Initiation of ACE inhibitor and ARBs in patients with advanced chronic kidney disease. 2023. Submitted. (not yet published)
   Google Scholar
• Lazich I, Bakris GL. Prediction and management of hyperkalemia across the spectrum of chronic kidney disease. Epub 2014 Apr 18. PMID: 25016403. Semin Nephrol. 2014;34(3):333–339. doi: 10.1016/j.semnephrol.2014.04.008
   PubMed Web of Science ®Google Scholar
• Jun M, Jardine MJ, Perkovic V, et al. Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: a general practice-based, observational study. PLoS One. 2019 [Published 2019 Mar 7];14(3):e0213192. doi: 10.1371/journal.pone.0213192
   PubMed Web of Science ®Google Scholar
• Epstein M, Reaven NL, Funk SE, et al. Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors. Am J Manag Care. 2015;21(11 Suppl):S212–S220.
   PubMed Web of Science ®Google Scholar
• Leon SJ, Whitlock R, Rigatto C, et al. Hyperkalemia-related discontinuation of renin-angiotensin-aldosterone system inhibitors and clinical outcomes in CKD: a population-based cohort study. Am J Kidney Dis. 2022;80(2):164–173.e1. doi: 10.1053/j.ajkd.2022.01.002
   PubMed Web of Science ®Google Scholar
• Fu EL, Evans M, Clase CM, et al. Stopping renin-angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: a nationwide study. J Am Soc Nephrol. 2021;32(2):424–435. doi: 10.1681/ASN.2020050682
   PubMed Web of Science ®Google Scholar
• Nakayama T, Morimoto K, Uchiyama K, et al. Effects of renin-angiotensin system inhibitors on the incidence of unplanned dialysis. Hypertens Res. 2022;45(6):1018–1027. doi: 10.1038/s41440-022-00877-5
   PubMed Web of Science ®Google Scholar
• Bhandari S, Mehta S, Khwaja A, et al. Renin-angiotensin system inhibition in advanced chronic kidney disease. N Engl J Med. 2022;387(22):2021–2032. doi: 10.1056/NEJMoa2210639
   PubMed Web of Science ®Google Scholar
• Sterns RH, Rojas M, Bernstein P, et al. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? J Am Soc Nephrol. 2010;21(5):733–735. doi: 10.1681/ASN.2010010079
   PubMed Web of Science ®Google Scholar
• Pitt B, Bakris GL. New potassium binders for the treatment of hyperkalemia: current data and opportunities for the future. Hypertension. 2015;66(4):731–738. doi: 10.1161/HYPERTENSIONAHA.115.04889
   PubMed Web of Science ®Google Scholar
• Weinstein J, Girard LP, Lepage S, et al. Prevention and management of hyperkalemia in patients treated with renin-angiotensin-aldosterone system inhibitors. CMAJ. 2021;193(48):E1836–E1841. doi: 10.1503/cmaj.210831
   PubMed Web of Science ®Google Scholar
• Rossignol P, Moulin B, Halimi JM, et al. État des lieux sur l’hyperkaliémie chronique persistante en France : consensus d’experts par une approche Delphi [Current status of persistent chronic hyperkalaemia in France: An expert consensus based on a Delphi approach]. Nephrol Ther. 2022;18(4):278–286. French Epub 2022 Jun 30. PMID: 35781425. doi: 10.1016/j.nephro.2021.10.008
   PubMedGoogle Scholar
• Neuen BL, Oshima M, Agarwal R, et al. Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials. Circulation. 2022;145(19):1460–1470. 39.918 Q1. Epub 2022 Apr 8. PMID: 35394821. doi: 10.1161/CIRCULATIONAHA.121.057736
   PubMed Web of Science ®Google Scholar
• Pagidipati NJ, Nelson AJ, Kaltenbach LA, et al. COORDINATE–diabetes site investigators. Coordinated care to optimize cardiovascular preventive therapies in type 2 diabetes: a randomized clinical trial. JAMA. 2023;329(15):1261–1270. PMID: 36877177; PMCID: PMC9989955. doi: 10.1001/jama.2023.2854
   PubMed Web of Science ®Google Scholar
• Martínez-González NA, Djalali S, Tandjung R, et al. Substitution of physicians by nurses in primary care: a systematic review and meta-analysis. BMC Health Serv Res. 2014 [Published 2014 May 12];14(1):214. doi: 10.1186/1472-6963-14-214
   PubMedGoogle Scholar
• Bryant-Lukosius D, Spichiger E, Martin J, et al. Framework for evaluating the impact of advanced practice nursing roles. J Nurs Scholarsh. 2016;48(2):201–209. doi: 10.1111/jnu.12199
   PubMed Web of Science ®Google Scholar
• Donald F, Kilpatrick K, Reid K, et al. Hospital to community transitional care by nurse practitioners: a systematic review of cost-effectiveness. Int J Nurs Stud. 2015;52(1):436–451. doi: 10.1016/j.ijnurstu.2014.07.011
   PubMed Web of Science ®Google Scholar